FDA Inspection 1123968 — Berlimed, S.A.

Berlimed, S.A. — FEI 3004492234

The FDA completed an inspection of Berlimed, S.A. on March 29, 2019 in Alcala de Henares. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 29, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Alcala de Henares (Spain)

Additional Details

Mutual Recognition Agreement (MRA)